Cargando…

Severe Hypophosphatemia Following Denosumab Administration in a Hemodialysis Patient with Progressive Prostate Cancer

In a 68-year-old man on maintenance hemodialysis (HD), severe anemia was detected. Bone marrow biopsy was performed for investigation of pancytopenia and pathological examination revealed adenocarcinoma of the prostate. Prostate specific antigen (PSA) was 574 ng/mL. After androgen deprivation therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuda, Hiroshi, Kaga, Kanya, Inahara, Masahiko, Araki, Kazuhiro, Kojima, Satoko, Naya, Yukio, Takano, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408148/ https://www.ncbi.nlm.nih.gov/pubmed/28462158 http://dx.doi.org/10.1016/j.eucr.2016.11.019

Ejemplares similares

High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted Therapy
por: Kojima, Satoko, et al.
Publicado: (2021)

ODP085 Denosumab Induced Severe Hypophosphatemia
por: Del Mar Morales Hernandez, Maria, et al.
Publicado: (2022)

Diagnosis and Management of Denosumab-Induced Hypocalcemia and Hypophosphatemia in the Setting of Metastatic Prostate Cancer
por: Flood, Michael G, et al.
Publicado: (2022)

Laparoscopic redo pyeloplasty with a buccal mucosal graft
por: Shimizu, Nobuhiko, et al.
Publicado: (2022)

False‐positive (123)I‐metaiodobenzylguanidine scan in a patient with renal cell carcinoma: A case of chromophobe renal cell carcinoma oncocytic variant with a complicated clinical course
por: Suyama, Takahito, et al.
Publicado: (2020)

SUN-514 Severe Hypophosphatemia and Worsening Secondary Hyperparathyroidism Following Treatment with Denosumab
por: Adepoju, Yewande, et al.
Publicado: (2019)

Intravenous Iron Administration and Hypophosphatemia in Clinical Practice
por: Hardy, S., et al.
Publicado: (2015)

PSAT189 Severe Hypocalcemia and Hypophosphatemia Associated with Denosumab use in a Chronic Myeloid Leukemia Patient on Imatinib
por: Shah, Tanvi, et al.
Publicado: (2022)

Denosumab Recovers Aortic Arch Calcification During Long-Term Hemodialysis
por: Suzuki, Shunji, et al.
Publicado: (2020)

Significance of Hypophosphatemia in Patients with Pneumonia
por: Morimoto, Yasuhiro, et al.
Publicado: (2022)

Recurrent severe hypophosphatemia following intravenous iron administration
por: Nataatmadja, Melissa Stephanie, et al.
Publicado: (2020)

Denosumab in Giant Cell Tumor of Bone: Current Status and Pitfalls
por: Li, Hengyuan, et al.
Publicado: (2020)

Changes of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic Patients
por: Suzuki, Takako, et al.
Publicado: (2017)

Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment
por: Nakamura, Yukio, et al.
Publicado: (2017)

Denosumab versus romosozumab for postmenopausal osteoporosis treatment
por: Kobayakawa, Tomonori, et al.
Publicado: (2021)

Nirogacestat and Hypophosphatemia
por: Gudsoorkar, Prakash, et al.
Publicado: (2023)

The Efficacy of Denosumab in Treating Spinal Aneurysmal Bone Cyst: A Case Report
por: Kotaka, Shinji, et al.
Publicado: (2023)

Pirin: a potential novel therapeutic target for castration‐resistant prostate cancer regulated by miR‐455‐5p
por: Arai, Takayuki, et al.
Publicado: (2018)

Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse events
por: Lim, Cynthia, et al.
Publicado: (2017)

Hypophosphatemia after hemodialysis and its association with some clinical complications in patients with chronic kidney disease
por: Ardalan, Mohammadreza, et al.
Publicado: (2022)

Tumor-induced hypophosphatemia
por: Mulani, M., et al.
Publicado: (2017)

Hypophosphatemia in cancer patients
por: Adhikari, Shreedhar, et al.
Publicado: (2021)

Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia
por: Weber, Thomas J, et al.
Publicado: (2022)

The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2014)

Efficacy of Denosumab for Osteoporosis in Two Patients with Adult-Onset Still’s Disease—Denosumab Efficacy in Osteoporotic Still’s Disease Patients
por: Kumaki, Daiki, et al.
Publicado: (2018)

Oral Squamous Cell Carcinoma (OSCC) Imitates Denosumab-Induced Osteonecrosis of the Mandibular Alveolus: A Diagnostic Challenge
por: Zisis, Vasileios, et al.
Publicado: (2023)

Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer
por: Muqeet Adnan, Mohammed, et al.
Publicado: (2014)

Future of bisphosphonates and denosumab for men with advanced prostate cancer
por: Iranikhah, Maryam, et al.
Publicado: (2014)

Tenofovir and Severe Symptomatic Hypophosphatemia
por: Kichloo, Asim, et al.
Publicado: (2019)

Early postkidney transplantation hypophosphatemia
por: Ghorbani, Maryam, et al.
Publicado: (2020)

Hypophosphatemia in Patients With Multiple Myeloma
por: Cancarevic, Ivan, et al.
Publicado: (2023)

Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature
por: Nasca, Vincenzo, et al.
Publicado: (2022)

Efficacy and safety of COVID-19 vaccines for patients with spinal tumors receiving denosumab treatment: An initial real−clinical experience study
por: Wang, Pengru, et al.
Publicado: (2023)

Evaluation of Safety for Scanning Carbon-Ion Radiotherapy in Hemodialysis Patients With Prostate Cancer
por: Takakusagi, Yosuke, et al.
Publicado: (2022)

Prostate cancer recurrence mimicking invasive urothelial cancer of the bladder
por: Okubo, Kazuki, et al.
Publicado: (2020)

Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2017)

Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials
por: Lu, Junjie, et al.
Publicado: (2023)

Case Report: Unresectable pulmonary metastases of a giant cell tumor of bone treated with denosumab: a case report and review of literature
por: Miwa, Shinji, et al.
Publicado: (2023)

Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course
por: Strickling, Jarred, et al.
Publicado: (2019)

Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer
por: Nishikawa, Rika, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2ggt4vlr0miv2d065rkpejgiln